Skip to content

Dogwood Therapeutics DWTX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$28.32M-28.8%-$34.26M-177%-$38.2M-567%-$24.74M-429%-$21.98M-334%
$40.37K$26.15K
$720.59K+70.9%$355.64K-25.3%$291.58K-45.0%$337.61K-42.2%$421.53K-29.4%
-$15.52M-23.8%-$15.62M-77.7%-$18.11M-339%-$15.75M-277%-$12.54M-205%
-$4.32M-128%-$8.33M-171%$8.22M+399%$10.52M+695%$15.3M+586%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Dogwood Therapeutics generate?
Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
Where does Dogwood Therapeutics's cash flow data come from?
Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.